• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种依赖于蛋白酶体、不依赖于 TAP 的胞饮抗原交叉呈递途径。

A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

机构信息

Institut National de la Santé et de la Recherché Médicale, Unité 1013, Paris 75015, France.

出版信息

EMBO Rep. 2011 Dec 1;12(12):1257-64. doi: 10.1038/embor.2011.203.

DOI:10.1038/embor.2011.203
PMID:22037009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3245693/
Abstract

Major histocompatibility complex (MHC) class I cross-presentation is thought to involve two pathways, one of which depends on both the TAP transporters and the proteasome and the other on neither. We found that preincubation of TAP-deficient dendritic cells at low temperature increases the density of MHC class I at the surface and fully restores cross-presentation of phagocytosed antigen, but not of soluble antigen internalized through receptors. Restoration of cross-presentation by TAP-deficient cells requires antigen degradation by the proteasome. Thus, TAP might mainly be required for recycling cell surface class I molecules during cross-presentation of phagocytosed antigens. Furthermore, phagosomes-but not endosomes-seem to have a TAP-independent mechanism to import peptides generated by cytosolic proteasome complexes.

摘要

主要组织相容性复合体(MHC)I 类交叉呈递被认为涉及两种途径,一种途径既依赖于 TAP 转运体又依赖于蛋白酶体,另一种途径则既不依赖于 TAP 转运体又不依赖于蛋白酶体。我们发现,在低温下预先孵育 TAP 缺陷型树突状细胞会增加 MHC I 类在表面的密度,并完全恢复吞噬抗原的交叉呈递,但不能恢复通过受体内化的可溶性抗原的交叉呈递。TAP 缺陷型细胞通过抗原降解蛋白酶体恢复交叉呈递。因此,TAP 可能主要用于在吞噬抗原的交叉呈递过程中循环利用细胞表面的 I 类分子。此外,吞噬体——而不是内体——似乎有一种不依赖 TAP 的机制来导入由细胞质蛋白酶体复合物产生的肽。

相似文献

1
A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.一种依赖于蛋白酶体、不依赖于 TAP 的胞饮抗原交叉呈递途径。
EMBO Rep. 2011 Dec 1;12(12):1257-64. doi: 10.1038/embor.2011.203.
2
Impact of the TAP-like transporter in antigen presentation and phagosome maturation.TAP 样转运体在抗原呈递和吞噬体成熟中的作用。
Mol Immunol. 2019 Sep;113:75-86. doi: 10.1016/j.molimm.2018.06.268. Epub 2018 Jun 23.
3
ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.内质网-吞噬体融合定义了树突状细胞中的MHC I类交叉呈递区室。
Nature. 2003 Sep 25;425(6956):397-402. doi: 10.1038/nature01911.
4
Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells.小鼠树突状细胞对可溶性蛋白进行交叉呈递的多种细胞内途径。
J Immunol. 2005 Feb 15;174(4):1879-87. doi: 10.4049/jimmunol.174.4.1879.
5
Proteasomal degradation within endocytic organelles mediates antigen cross-presentation.蛋白酶体在内涵体中的降解介导抗原交叉呈递。
EMBO J. 2019 Aug 15;38(16):e99266. doi: 10.15252/embj.201899266. Epub 2019 Jul 4.
6
Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.人树突状细胞对合成长肽的交叉呈递:一个依赖于内质网相关蛋白降解(ERAD)组分p97/VCP而非Sec61和/或Derlin-1的过程。
PLoS One. 2014 Feb 27;9(2):e89897. doi: 10.1371/journal.pone.0089897. eCollection 2014.
7
Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.病毒样颗粒上表位通过 MHC I 受体再循环途径的交叉呈递。
Immunol Cell Biol. 2011 Aug;89(6):681-8. doi: 10.1038/icb.2010.161. Epub 2011 Jan 11.
8
TAP-Dependent and -Independent Peptide Import into Dendritic Cell Phagosomes.依赖TAP及不依赖TAP的肽段导入树突状细胞吞噬体
J Immunol. 2016 Nov 1;197(9):3454-3463. doi: 10.4049/jimmunol.1501925. Epub 2016 Sep 23.
9
Control of cross-presentation during dendritic cell maturation.树突状细胞成熟过程中交叉呈递的调控。
Eur J Immunol. 2004 Feb;34(2):398-407. doi: 10.1002/eji.200324508.
10
Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.在体外和体内,利什曼原虫抗原通过与抗原加工无关的途径相关转运体呈递给CD8 + T细胞。
J Immunol. 2006 Sep 15;177(6):3525-33. doi: 10.4049/jimmunol.177.6.3525.

引用本文的文献

1
Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy.将异种抗原进行细胞内强制降解作为基于细胞的癌症免疫疗法的一种方式。
iScience. 2025 Feb 4;28(3):111957. doi: 10.1016/j.isci.2025.111957. eCollection 2025 Mar 21.
2
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?1 型经典树突状细胞交叉呈递的最新进展——胞质溶胶、空泡还是两者兼而有之?
Curr Opin Immunol. 2023 Aug;83:102350. doi: 10.1016/j.coi.2023.102350. Epub 2023 Jun 3.
3
Pathways of MHC I cross-presentation of exogenous antigens.MHC I 类分子交叉呈递外源抗原的途径。
Semin Immunol. 2023 Mar;66:101729. doi: 10.1016/j.smim.2023.101729. Epub 2023 Feb 16.
4
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.不同途径的 MHC-I 递送至吞噬体及其对 CD8+T 细胞免疫的影响。
Semin Immunol. 2023 Mar;66:101713. doi: 10.1016/j.smim.2023.101713. Epub 2023 Jan 25.
5
The evolving biology of cross-presentation.交叉呈递的生物学演变。
Semin Immunol. 2023 Mar;66:101711. doi: 10.1016/j.smim.2023.101711. Epub 2023 Jan 14.
6
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.树突状细胞的交叉呈递增加和使用 Arp2/3 抑制剂 CK666 增强抗肿瘤治疗。
Br J Cancer. 2023 Apr;128(6):982-991. doi: 10.1038/s41416-022-02135-4. Epub 2023 Jan 11.
7
Vaccine adjuvants to engage the cross-presentation pathway.疫苗佐剂以激活交叉呈递途径。
Front Immunol. 2022 Aug 1;13:940047. doi: 10.3389/fimmu.2022.940047. eCollection 2022.
8
Nanoscale organization of the MHC I peptide-loading complex in human dendritic cells.人类树突状细胞中 MHC I 肽加载复合物的纳米级组织。
Cell Mol Life Sci. 2022 Aug 10;79(9):477. doi: 10.1007/s00018-022-04472-2.
9
Homotypic and heterotypic associations of MHC class I molecules at the cell surface.细胞表面MHC I类分子的同型和异型缔合。
Curr Res Immunol. 2022 May 23;3:85-99. doi: 10.1016/j.crimmu.2022.05.001. eCollection 2022.
10
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.通过上调溶酶体蛋白酶组织蛋白酶 S 增强人结直肠癌相关成纤维细胞中的抗原交叉呈递。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003591.

本文引用的文献

1
Defective cross-presentation of viral antigens in GILT-free mice.GILT 缺失小鼠中病毒抗原的交叉呈递缺陷。
Science. 2010 Jun 11;328(5984):1394-8. doi: 10.1126/science.1189176.
2
Fusion proteins for versatile antigen targeting to cell surface receptors reveal differential capacity to prime immune responses.融合蛋白可将多种抗原靶向细胞表面受体,从而揭示出诱导免疫反应的不同能力。
J Immunol. 2010 Jun 15;184(12):6855-64. doi: 10.4049/jimmunol.0902555. Epub 2010 May 14.
3
Measuring pH, ROS production, maturation, and degradation in dendritic cell phagosomes using cytofluorometry-based assays.使用基于细胞荧光测定法检测树突状细胞吞噬体中的pH值、活性氧生成、成熟和降解。
Methods Mol Biol. 2010;595:383-402. doi: 10.1007/978-1-60761-421-0_25.
4
MHC molecules and microbial antigen processing in phagosomes.主要组织相容性复合体分子与吞噬体中的微生物抗原加工
Curr Opin Immunol. 2009 Feb;21(1):98-104. doi: 10.1016/j.coi.2009.01.001. Epub 2009 Feb 11.
5
MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.MHC I类分子在内体和溶酶体中的运输与树突状细胞中外源抗原的加载过程相吻合。
PLoS One. 2008 Sep 19;3(9):e3247. doi: 10.1371/journal.pone.0003247.
6
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.交叉提呈与内源性抗原提呈的空间和机制分离。
Nat Immunol. 2008 May;9(5):558-66. doi: 10.1038/ni.1601. Epub 2008 Mar 30.
7
Antigen release kinetics in the phagosome are critical to cross-presentation efficiency.吞噬小体中的抗原释放动力学对于交叉呈递效率至关重要。
J Immunol. 2008 Feb 1;180(3):1576-83. doi: 10.4049/jimmunol.180.3.1576.
8
Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy.蛋白酶体的功能:从蛋白质降解、免疫监视到癌症治疗
Biochem Soc Trans. 2007 Feb;35(Pt 1):12-7. doi: 10.1042/BST0350012.
9
Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules.MHC I类分子交叉提呈过程中内吞途径与内质网之间的串扰。
Curr Opin Immunol. 2007 Feb;19(1):66-72. doi: 10.1016/j.coi.2006.11.017. Epub 2006 Dec 6.
10
NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells.NOX2控制吞噬体pH值,以调节树突状细胞交叉呈递过程中的抗原处理。
Cell. 2006 Jul 14;126(1):205-18. doi: 10.1016/j.cell.2006.05.035.